Ernexa Therapeutics (ERNAW) Amortization of Goodwill (2020 - 2026)

Ernexa Therapeutics (ERNAW) reported Amortization of Goodwill of $2.0 million for Q1 2026, up 202.11% quarter-over-quarter from $662000.0 in Q1 2020.

Ernexa Therapeutics (ERNAW) Amortization of Goodwill (2020 - 2026) Analysis & Trends

Ernexa Therapeutics has reported Amortization of Goodwill for 2 years, with the latest figure at $2.0 million in Q1 2026.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn -
7 Psyence Biomedical 212.16 Bn 212.16 Bn -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn
9 Abivax 91.96 Bn 91.96 Bn -
10 Ernexa Therapeutics - - -

Historic Data

Download Data
DateValue
Mar 31, 2026 2.00 Mn
Mar 31, 2026 2.00 Mn
Mar 31, 2020 662,000.00
Mar 31, 2020 662,000.00